DOD Peer Reviewed Cancer, Idea Award
Closed Posted
- Opportunity number
- HT942525PRCRPIA
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Grant
- Category
-
- Science and Technology and other Research and Development
- Eligible applicants
-
- Unrestricted
- Points of contact
-
- eBRAP Help Desk help@ebrap.org (301) 682-5507
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Department of the Army Medical Command is seeking applicants for the Fiscal Year 2025 (FY25) Peer Reviewed Cancer Research Program (PRCRP) Idea Award. This funding opportunity supports innovative, untested, high-risk/potentially high-reward cancer research to advance knowledge in patient care and treatment options for military service members, veterans, and other military beneficiaries. The proposed projects should demonstrate creative thinking and innovation, without requiring preliminary data. Key submission dates include a pre-application deadline of June 20, 2025, an invitation to submit a full application by July 23, 2025, and a full application submission deadline of September 25, 2025. The award is open to extramural and intramural organizations, including foreign and domestic, for-profit and nonprofit entities.
The CDMRP expects to allot approximately $14 million to fund approximately 25 Idea Award applications, with a total cost cap of $560,000 per award and a maximum performance period of 2 years. The federal grant opportunity is assigned to the Military Medical Research and Development (CFDA 12.420) program, which supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public.
Synopsis
Summary: The fiscal year 2025 (FY25) Peer Reviewed Cancer Research Program (PRCRP) Idea Award (IA) supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or basic cancer research. The advancement of knowledge in cancer research, patient care, and/or treatment options in the Military Health System (MHS) is critical to active-duty Service Members, Veterans, other military beneficiaries, and the American public.
Distinctive Features:
• The proposed project should demonstrate creative thinking and innovation.
• Incremental advances, the next logical step, or switching a model system from one cancer to another cancer are not appropriate for this award.
• Inclusion of preliminary data is not required; however, the project must be based on strong scientific rationale.
Funding Details: (New for FY25) Funding limits are now listed as total cost limits, which is the combination of both direct and indirect costs.
Files
| File | Type | Posted |
|---|---|---|
| HT942525PRCRPIA_GG.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity